Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study-Reference-Cited by-同舟云学术

Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study

Published:2010-05-23 Issue:8 Volume:29 Page:913-920
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Kellner Herbert,Bornholdt Klaus,Hein Gert

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://www.springerlink.com/index/pdf/10.1007/s10067-010-1425-3

Reference21 articles.

1. Lard LR, Visser H, Speyer I et al (2001) Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 111:446–51

2. Emery P, Salmon M (1995) Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 54:944–7

3. Aletaha D, Eberl G, Nell VP et al (2004) Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey. Ann Rheum Dis 63:1269–75

4. Machold KP, Stamm TA, Eberl GJ et al (2002) Very recent onset arthritis—clinical, laboratory, and radiological findings during the first year of disease. J Rheumatol 29:2278–87

5. Sharp JT, Strand V, Leung H et al (2000) Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum 43:495–505

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Efficient Access to 5‐(1,2,3‐Triazol‐1‐yl)isoxazoles – Previously Unknown Structural Type of Triazole‐isoxazole Hybrid Molecule;Asian Journal of Organic Chemistry;2022-08-04

2. Lack of association between CYB5A gene rs1790834 polymorphism and the response to leflunomide in women with rheumatoid arthritis;European Journal of Clinical Pharmacology;2021-06-23

3. Cardiovascular effects of approved drugs for rheumatoid arthritis;Nature Reviews Rheumatology;2021-04-08

4. Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future;Chinese Medical Journal;2019-12-13

5. Quality of life and clinical outcomes in Polish patients with high activity rheumatoid arthritis treated with leflunomide (Arava®) in Therapeutic Program: A retrospective analysis of data from the PLUS study;Advances in Clinical and Experimental Medicine;2019-10-29